Unresectable Non-small Cell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch Unresectable Non-small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC (NCT04416633) | AstraZeneca | 2021-11-30 |
Track Unresectable Non-small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.